Brian McKelligon, President/CEO at Akoya Biosciences, Inc. (AKYA), sold 5,000 shares at $5.71 ($29K) on 2023-06-06, disclosed to the SEC on 2023-06-06.
Scheduled sale ($29k) by President/CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| AKYA | SELL | 2024-03-22 | $37K | — | Filing → |
| AKYA | SELL | 2024-03-22 | $37K | — | Filing → |
| AKYA | SELL | 2023-12-20 | $34K | — | Filing → |